Proficio Capital Partners LLC Makes New $750,000 Investment in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)
Proficio Capital Partners LLC purchased a new position in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,674 shares of the company’s stock, valued at approximately $750,000. Other institutional investors also recently bought and sold […]
Proficio Capital Partners LLC purchased a new position in shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 14,674 shares of the company’s stock, valued at approximately $750,000. Other institutional investors also recently bought and sold […]
